COMP <GO>
OCUL vs ETON // 10Y YIELD & FRED MACRO BETA
Ocular Therapeutix Inc. (NASDAQ) VS. Eton Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: OCUL 2
— ETON 8
■ METRIC PARITY
LAST: $6.73 (-3.44%) • MKT CAP: $1.53B
macro-sensitivity
—
LAST: $50.81 (-2.63%) • MKT CAP: $1.49B
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OCUL VS. ETON)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OCUL | ETON | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 87.30% | 53.50% | +33.80 | OCUL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -0.90% | -34.10 | ETON | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.51% | 0.66% | -14.17 | ETON | /fcf-yield <GO> |
| Operating Margin | -60.00% | -1.10% | -58.90 | ETON | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -5.80% | -54.20 | ETON | /net-margins <GO> |
| Revenue Growth (YoY) | -18.50% | 104.90% | -123.40 | ETON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.31 | 13.37 | -9.06 | ETON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | ETON | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.3 | 47.9 | -4.60 | ETON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.53B | $1.49B | $39.3M | OCUL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OCUL REV | ETON REV | OCUL GROSS % | ETON GROSS % | OCUL FCF | ETON FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $52.0M | $80.0M | 87.3% | 53.5% | -$216.9M | $10.2M |
| FY 2024 | $63.7M | $39.0M | 91.2% | 60.0% | -$136.0M | $943.0K |
| FY 2023 | $58.4M | $31.6M | — | — | -$70.2M | $6.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OCUL // BETA —
ETON // BETA —